Process for the preparation of compounds useful as inhibitors of SGLT

Details for Australian Patent Application No. 2009305413 (hide)

Owner Mitsubishi Tanabe Pharma Corporation Janssen Pharmaceutica NV

Inventors Filliers, Walter Ferdinand Maria; Broeckx, Rudy Laurent Maria; Nieste, Patrick Hubert J.; Hatsuda, Masanori; Yoshinaga, Masahiko; Yada, Mitsuhiro; Teleha, Christopher

Agent Shelston IP

Pub. Number AU-A-2009305413

PCT Pub. Number WO2010/043682

Priority 12/578,934 14.10.09 US; 61/106,231 17.10.08 US; 61/106,260 17.10.08 US

Filing date 15 October 2009

Wipo publication date 22 April 2010

International Classifications

C07D 333/12 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/043682 Priority application(s): WO2010/043682

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305419-Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

2009305406-Pharmaceutical product for up-dosing of allergy vaccine